Emergent BioSolutions (EBS) Misses Q2 EPS by $1.21

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. BA
7. SPY
8. HOOD
9. INTC
10. JBLU

Go back to Emergent BioSolutions (EBS) Misses Q2 EPS by $1.21

Emergent BioSolutions Reports Financial Results For Second Quarter 2021

July 29, 2021 4:05 PM EDT

Reaffirms 2021 Full Year Forecast for Revenues and Profit

GAITHERSBURG, Md., July 29, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2021.

Our second quarter performance demonstrates the strength of our strategy and diversified business model, said Robert G. Kramer, president and chief executive officer of Emergent BioSolutions. Through continued investment and innovation, we will play an important role in helping deliver solutions to the public health threats we face. We are proud to be resuming... More